Sanguine, a leading technology company providing services to the personalized medicine and biomedical research market, recently announced that they will be expanding their services to improve clinical trial efficiency through enhanced patient recruitment, retention and trial procedures. Sanguine, which primarily operated in the pre-clinical space until now, will be fulfilling a big need in later stage clinical development through a combination of their smart technology and adaptable mobile health force.
Enrollment in Pharmatech’s Revolutionary AccessPPM Program Launches
Pharmatech commences enrollment for its AccessPPM program after a two year investment into this game-changing method for matching cancer patients to cancer clinical trials.
New Versions of JMP Life Sciences Solutions Fuel Discoveries in Clinical Trials, Genomics Research
Risk-based monitoring methods new in JMP® Clinical software from SAS limit costly on-site audits of source data during clinical trials while protecting study participants. JMP Genomics now offers enhanced capabilities for analyzing data related to agriculture, pharmacogenomics, biotechnology and more.
Thomson Reuters Launches New Clinical Trial Intelligence Solution
The Intellectual Property & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, recently announced the addition of Clinical Trials Intelligence to the Thomson Reuters Cortellis suite, the industry’s most comprehensive information solution for drug discovery and development.